A citation-based method for searching scientific literature

F Grams, P Reinemer, J C Powers, T Kleine, M Pieper, H Tschesche, R Huber, W Bode. Eur J Biochem 1995
Times Cited: 148







List of co-cited articles
1070 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
F Grams, M Crimmin, L Hinnes, P Huxley, M Pieper, H Tschesche, W Bode. Biochemistry 1995
136
44


Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.
E Morgunova, A Tuuttila, U Bergmann, M Isupov, Y Lindqvist, G Schneider, K Tryggvason. Science 1999
419
34

Matrilysin-inhibitor complexes: common themes among metalloproteases.
M F Browner, W W Smith, A L Castelhano. Biochemistry 1995
208
31

Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.
B Lovejoy, A Cleasby, A M Hassell, K Longley, M A Luther, D Weigl, G McGeehan, A B McElroy, D Drewry, M H Lambert. Science 1994
269
29

Structure of human neutrophil collagenase reveals large S1' specificity pocket.
T Stams, J C Spurlino, D L Smith, R C Wahl, T F Ho, M W Qoronfleh, T M Banks, B Rubin. Nat Struct Biol 1994
158
28

Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
J W Becker, A I Marcy, L L Rokosz, M G Axel, J J Burbaum, P M Fitzgerald, P M Cameron, C K Esser, W K Hagmann, J D Hermes. Protein Sci 1995
229
27

Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study.
P Reinemer, F Grams, R Huber, T Kleine, S Schnierer, M Piper, H Tschesche, W Bode. FEBS Lett 1994
123
27

Matrix metalloproteinases.
H Nagase, J F Woessner. J Biol Chem 1999
26

Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.
B Lovejoy, A R Welch, S Carr, C Luong, C Broka, R T Hendricks, J A Campbell, K A Walker, R Martin, H Van Wart,[...]. Nat Struct Biol 1999
217
26

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
F X Gomis-Rüth, K Maskos, M Betz, A Bergner, R Huber, K Suzuki, N Yoshida, H Nagase, K Brew, G P Bourenkov,[...]. Nature 1997
464
26

Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller.
J Li, P Brick, M C O'Hare, T Skarzynski, L F Lloyd, V A Curry, I M Clark, H F Bigg, B L Hazleman, T E Cawston. Structure 1995
219
24

Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor.
N Borkakoti, F K Winkler, D H Williams, A D'Arcy, M J Broadhurst, P A Brown, W H Johnson, E J Murray. Nat Struct Biol 1994
166
24

1.56 A structure of mature truncated human fibroblast collagenase.
J C Spurlino, A M Smallwood, D D Carlton, T M Banks, K J Vavra, J S Johnson, E R Cook, J Falvo, R C Wahl, T A Pulvino. Proteins 1994
157
24

Design and therapeutic application of matrix metalloproteinase inhibitors.
M Whittaker, C D Floyd, P Brown, A J Gearing. Chem Rev 1999
595
24


On the size of the active site in proteases. I. Papain.
I Schechter, A Berger. Biochem Biophys Res Commun 1967
23




Structural properties of matrix metalloproteinases.
W Bode, C Fernandez-Catalan, H Tschesche, F Grams, H Nagase, K Maskos. Cell Mol Life Sci 1999
260
20

Structure of malonic acid-based inhibitors bound to human neutrophil collagenase. A new binding mode explains apparently anomalous data.
H Brandstetter, R A Engh, E G Von Roedern, L Moroder, R Huber, W Bode, F Grams. Protein Sci 1998
35
57



The NMR structure of the inhibited catalytic domain of human stromelysin-1.
P R Gooley, J F O'Connell, A I Marcy, G C Cuca, S P Salowe, B L Bush, J D Hermes, C K Esser, W K Hagmann, J P Springer. Nat Struct Biol 1994
127
15

X-ray structure of human stromelysin catalytic domain complexed with nonpeptide inhibitors: implications for inhibitor selectivity.
A G Pavlovsky, M G Williams, Q Z Ye, D F Ortwine, C F Purchase, A D White, V Dhanaraj, B D Roth, L L Johnson, D Hupe,[...]. Protein Sci 1999
68
22

Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits.
L J MacPherson, E K Bayburt, M P Capparelli, B J Carroll, R Goldstein, M R Justice, L Zhu, S Hu, R A Melton, L Fryer,[...]. J Med Chem 1997
280
15

Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itself.
B Lovejoy, A M Hassell, M A Luther, D Weigl, S R Jordan. Biochemistry 1994
124
15

Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
L Chen, T J Rydel, F Gu, C M Dunaway, S Pikul, K M Dunham, B L Barnett. J Mol Biol 1999
61
24

Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Lisa M Coussens, Barbara Fingleton, Lynn M Matrisian. Science 2002
15

Matrix metalloproteinases.
L L Johnson, R Dyer, D J Hupe. Curr Opin Chem Biol 1998
223
14

Matrix metalloproteinases: a review.
H Birkedal-Hansen, W G Moore, M K Bodden, L J Windsor, B Birkedal-Hansen, A DeCarlo, J A Engler. Crit Rev Oral Biol Med 1993
14

Matrix metalloproteinase inhibitors in arthritis.
K M Bottomley, W H Johnson, D S Walter. J Enzyme Inhib 1998
87
16

Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.
H Matter, W Schwab, D Barbier, G Billen, B Haase, B Neises, M Schudok, W Thorwart, H Schreuder, V Brachvogel,[...]. J Med Chem 1999
70
20

Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
R Kiyama, Y Tamura, F Watanabe, H Tsuzuki, M Ohtani, M Yodo. J Med Chem 1999
78
17



Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
A L Gall, M Ruff, R Kannan, P Cuniasse, A Yiotakis, V Dive, M C Rio, P Basset, D Moras. J Mol Biol 2001
75
18

A matrix metalloproteinase expressed on the surface of invasive tumour cells.
H Sato, T Takino, Y Okada, J Cao, A Shinagawa, E Yamamoto, M Seiki. Nature 1994
13

Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
B C Finzel, E T Baldwin, G L Bryant, G F Hess, J W Wilks, C M Trepod, J E Mott, V P Marshall, G L Petzold, R A Poorman,[...]. Protein Sci 1998
64
20

Matrix metalloproteinases: structures, evolution, and diversification.
I Massova, L P Kotra, R Fridman, S Mobashery. FASEB J 1998
594
13

Two crystal structures of human neutrophil collagenase, one complexed with a primed- and the other with an unprimed-side inhibitor: implications for drug design.
E Gavuzzo, G Pochetti, F Mazza, C Gallina, B Gorini, S D'Alessio, M Pieper, H Tschesche, P A Tucker. J Med Chem 2000
39
33



Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.
J Ottl, D Gabriel, G Murphy, V Knäuper, Y Tominaga, H Nagase, M Kröger, H Tschesche, W Bode, L Moroder. Chem Biol 2000
92
13

Protease inhibitors: current status and future prospects.
D Leung, G Abbenante, D P Fairlie. J Med Chem 2000
655
12


Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
R Lang, A Kocourek, M Braun, H Tschesche, R Huber, W Bode, K Maskos. J Mol Biol 2001
80
15

How matrix metalloproteinases regulate cell behavior.
M D Sternlicht, Z Werb. Annu Rev Cell Dev Biol 2001
12

Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase.
Patricia A Elkins, Yen Sen Ho, Ward W Smith, Cheryl A Janson, Karla J D'Alessio, Michael S McQueney, Maxwell D Cummings, Anne M Romanic. Acta Crystallogr D Biol Crystallogr 2002
112
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.